---
title: "NHS national Generic Pharmaceuticals Transition 2021_2"
ocid: "ocds-h6vhtk-028bae"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028bae"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-028bae.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-028bae.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)"
published: "2021-06-04"
---

# NHS national Generic Pharmaceuticals Transition 2021_2

Buyer: THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)  
Current stage: Award  
OCID: ocds-h6vhtk-028bae

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028bae)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-028bae.json)

## Summary

The NHS Commissioning Board, operating under the name of NHS England, has initiated a procurement process titled "NHS National Generic Pharmaceuticals Transition 2021_2" within the pharmaceuticals industry. This ongoing tender, classified under CPV code 33600000, aims to establish a framework agreement lasting up to 39 months, including options to extend. The tender encompasses multiple lots with specific call-off periods for various pharmaceutical products, commencing on 15 June 2021 and concluding with different end dates extending until January 2023. Bids must be submitted electronically through the eTendering portal by 23 February 2021, at which point the bids will be opened at the designated address in Runcorn.

This procurement presents significant opportunities for businesses within the pharmaceutical sector, particularly those specialising in generic pharmaceuticals and healthcare services. Companies that are adept in delivering oral and non-parenteral products, as well as hospital housekeeping services, would be well-positioned to compete for this contract. Given the framework's extensive potential participant capacity and the considerable contract values across various lots, there is ample scope for both small and large businesses to engage and expand their market presence through successful bidding.

## Notice

Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: Allregions: 15/06/2021 to 28/02/2022 (8.5months)Transition CESW: 15/06/2021 to30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5months)NWLN: 15/06/2021 to 31/01/2022 (7.5months)Hospital Only Housekeeping Products:All regions: 15/06/2021 to 31/01/2022 (7.5 months)

### Lot Information

Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Plus options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 8.5 months)

Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: options to extend (at the Authority's sole discretion) for up to a further 19.5 months)

Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 12.5 months)

Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 12.5 months)

Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: options to extend (at the Authority's sole discretion) for up to a further 19.5 months)

Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Plus options to extend (at the Authority's sole discretion) for up to a further 7.5 months)Hide Section - II.2.12) eCatalogue requirementsII.2.12) eCatalogue requirements

Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 8.5 months)

Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions

NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend (at the Authority's sole discretion) for up to a further 7.5 months)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/012546-2021 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 4 Jun 2021 |
| Submission deadline | 23 Feb 2021 |
| Future notice date | Not specified |
| Award date | 6 May 2021 |
| Contract period | 14 Jun 2021 - 31 Jan 2022 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £115,932,694 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Active, Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 17 |
| Supplier names | ACCORD-UK; AMAROX; ASPIRE PHARMA; BRISTOL LABORATORIES; BROWN AND BURK; CIPLA (EU; DAY LEWIS MEDICAL; DR.REDDY'S LABORATORIES (UK; LABORATORIO REIG JOFRE; LEXON; MILPHARM LTD/AUROBINBDO; MORNINGSIDE PHARMAEUTICALS; NEON HEALTHCARE; RANBAXY; SELECTIVE SUPPLIES; THORNTON AND ROSS; WAVERLEY PHARMA EUROPE |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products
- 33690000 - Various medicinal products

## Release History

- 4 Jun 2021 at 10:32 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/012546-2021
- 19 Jan 2021 at 17:50 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/001112-2021

## Notice URLs

- http://health.atamis.co.uk
- http://health.atamis.co.ukCandidates
- https://supplierregistration.cabinetoffice.gov.ukand
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028bae. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-028bae.json.